The global cardiac rhythm management market is expected to grow at a CAGR of 4% during the forecast year 2022 to 2032 from US$ 22.1 Bn in 2021 to US$ 26.8 Bn in 2025. Around 30% of total death worldwide is caused by cardiovascular diseases, of which major part is accounted by heart diseases.The risk factors of heart.
Around 30% of total death worldwide is caused by cardiovascular diseases, of which major part is accounted by heart diseases.The risk factors of heart disease includes elevated cholesterol levels, diabetes mellitus, cigarette smoking, obesity and hypertension.Frequency of these factors varies demographically, i.e. o.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Cardiac Monitoring & Cardiac Rhythm Management market accounted for $25,152.56 million in 2019 and is expected to reach $48,665.45 million by 2027 growing at a CAGR of 8.6% during the forecast period. The rising rate of cardiac disorders, patient awareness, and the growing number of unmet medical needs in developing and underdeveloped countries are the major factors propelling the growth of the market. However, limited insurance coverage options and the high cost of these devices are hampering the growth of the market.
The cardiac monitoring enables the observing of a patient s cardiac activity. Cardiac rhythm management maintains a normal cardiac rhythm in patients suffering from irregular heart rate and rhythm disorder. The cardiac monitoring & cardiac rhythm management include devices that help the patients to manage and treat arrhythmia-related diseases. These devices play a crucial role in t